Autologous Matrix-induced Chondrogenesis Market - Global Outlook and Forecast 2022-2028

January 2022 | 65 pages | ID: A955ED984822EN
Market Monitor Global

Abstracts

Autologous matrix-induced chondrogenesis (AMIC) is a 1-step cartilage restoration technique that combines microfracture with the use of an exogenous scaffold.

This report contains market size and forecasts of Autologous Matrix-induced Chondrogenesis in Global, including the following market information:

Global Autologous Matrix-induced Chondrogenesis Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Autologous Matrix-induced Chondrogenesis market was valued at 106.9 million in 2021 and is projected to reach US$ 147.3 million by 2028, at a CAGR of 4.7% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Hyaluronic Acid Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Autologous Matrix-induced Chondrogenesis include JRI Orthopaedics Ltd, BioTissue, Anika Therapeutics, B. Braun Melsungen, Arthro-Kinetics, Geistlich Pharma, CartiHeal, Matricel and Smith & Nephew and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Autologous Matrix-induced Chondrogenesis companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Autologous Matrix-induced Chondrogenesis Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Autologous Matrix-induced Chondrogenesis Market Segment Percentages, by Type, 2021 (%)

• Hyaluronic Acid
• Collagen
• Polyethylene Glycol (PEG)
• Poly Lactic-Co-Glycolic Acid (PGLA)

Global Autologous Matrix-induced Chondrogenesis Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Autologous Matrix-induced Chondrogenesis Market Segment Percentages, by Application, 2021 (%)

• Knees Joint
• Other

Global Autologous Matrix-induced Chondrogenesis Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Autologous Matrix-induced Chondrogenesis Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Autologous Matrix-induced Chondrogenesis revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Autologous Matrix-induced Chondrogenesis revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• JRI Orthopaedics Ltd
• BioTissue
• Anika Therapeutics
• B. Braun Melsungen
• Arthro-Kinetics
• Geistlich Pharma
• CartiHeal
• Matricel
• Smith & Nephew
• Zimmer Biomet Holdings

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Autologous Matrix-induced Chondrogenesis Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Autologous Matrix-induced Chondrogenesis Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL AUTOLOGOUS MATRIX-INDUCED CHONDROGENESIS OVERALL MARKET SIZE

2.1 Global Autologous Matrix-induced Chondrogenesis Market Size: 2021 VS 2028
2.2 Global Autologous Matrix-induced Chondrogenesis Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Autologous Matrix-induced Chondrogenesis Players in Global Market
3.2 Top Global Autologous Matrix-induced Chondrogenesis Companies Ranked by Revenue
3.3 Global Autologous Matrix-induced Chondrogenesis Revenue by Companies
3.4 Top 3 and Top 5 Autologous Matrix-induced Chondrogenesis Companies in Global Market, by Revenue in 2021
3.5 Global Companies Autologous Matrix-induced Chondrogenesis Product Type
3.6 Tier 1, Tier 2 and Tier 3 Autologous Matrix-induced Chondrogenesis Players in Global Market
  3.6.1 List of Global Tier 1 Autologous Matrix-induced Chondrogenesis Companies
  3.6.2 List of Global Tier 2 and Tier 3 Autologous Matrix-induced Chondrogenesis Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Autologous Matrix-induced Chondrogenesis Market Size Markets, 2021 & 2028
  4.1.2 Hyaluronic Acid
  4.1.3 Collagen
  4.1.4 Polyethylene Glycol (PEG)
  4.1.5 Poly Lactic-Co-Glycolic Acid (PGLA)
4.2 By Type - Global Autologous Matrix-induced Chondrogenesis Revenue & Forecasts
  4.2.1 By Type - Global Autologous Matrix-induced Chondrogenesis Revenue, 2017-2022
  4.2.2 By Type - Global Autologous Matrix-induced Chondrogenesis Revenue, 2023-2028
  4.2.3 By Type - Global Autologous Matrix-induced Chondrogenesis Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Autologous Matrix-induced Chondrogenesis Market Size, 2021 & 2028
  5.1.2 Knees Joint
  5.1.3 Other
5.2 By Application - Global Autologous Matrix-induced Chondrogenesis Revenue & Forecasts
  5.2.1 By Application - Global Autologous Matrix-induced Chondrogenesis Revenue, 2017-2022
  5.2.2 By Application - Global Autologous Matrix-induced Chondrogenesis Revenue, 2023-2028
  5.2.3 By Application - Global Autologous Matrix-induced Chondrogenesis Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Autologous Matrix-induced Chondrogenesis Market Size, 2021 & 2028
6.2 By Region - Global Autologous Matrix-induced Chondrogenesis Revenue & Forecasts
  6.2.1 By Region - Global Autologous Matrix-induced Chondrogenesis Revenue, 2017-2022
  6.2.2 By Region - Global Autologous Matrix-induced Chondrogenesis Revenue, 2023-2028
  6.2.3 By Region - Global Autologous Matrix-induced Chondrogenesis Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Autologous Matrix-induced Chondrogenesis Revenue, 2017-2028
  6.3.2 US Autologous Matrix-induced Chondrogenesis Market Size, 2017-2028
  6.3.3 Canada Autologous Matrix-induced Chondrogenesis Market Size, 2017-2028
  6.3.4 Mexico Autologous Matrix-induced Chondrogenesis Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Autologous Matrix-induced Chondrogenesis Revenue, 2017-2028
  6.4.2 Germany Autologous Matrix-induced Chondrogenesis Market Size, 2017-2028
  6.4.3 France Autologous Matrix-induced Chondrogenesis Market Size, 2017-2028
  6.4.4 U.K. Autologous Matrix-induced Chondrogenesis Market Size, 2017-2028
  6.4.5 Italy Autologous Matrix-induced Chondrogenesis Market Size, 2017-2028
  6.4.6 Russia Autologous Matrix-induced Chondrogenesis Market Size, 2017-2028
  6.4.7 Nordic Countries Autologous Matrix-induced Chondrogenesis Market Size, 2017-2028
  6.4.8 Benelux Autologous Matrix-induced Chondrogenesis Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Autologous Matrix-induced Chondrogenesis Revenue, 2017-2028
  6.5.2 China Autologous Matrix-induced Chondrogenesis Market Size, 2017-2028
  6.5.3 Japan Autologous Matrix-induced Chondrogenesis Market Size, 2017-2028
  6.5.4 South Korea Autologous Matrix-induced Chondrogenesis Market Size, 2017-2028
  6.5.5 Southeast Asia Autologous Matrix-induced Chondrogenesis Market Size, 2017-2028
  6.5.6 India Autologous Matrix-induced Chondrogenesis Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Autologous Matrix-induced Chondrogenesis Revenue, 2017-2028
  6.6.2 Brazil Autologous Matrix-induced Chondrogenesis Market Size, 2017-2028
  6.6.3 Argentina Autologous Matrix-induced Chondrogenesis Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Autologous Matrix-induced Chondrogenesis Revenue, 2017-2028
  6.7.2 Turkey Autologous Matrix-induced Chondrogenesis Market Size, 2017-2028
  6.7.3 Israel Autologous Matrix-induced Chondrogenesis Market Size, 2017-2028
  6.7.4 Saudi Arabia Autologous Matrix-induced Chondrogenesis Market Size, 2017-2028
  6.7.5 UAE Autologous Matrix-induced Chondrogenesis Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 JRI Orthopaedics Ltd
  7.1.1 JRI Orthopaedics Ltd Corporate Summary
  7.1.2 JRI Orthopaedics Ltd Business Overview
  7.1.3 JRI Orthopaedics Ltd Autologous Matrix-induced Chondrogenesis Major Product Offerings
  7.1.4 JRI Orthopaedics Ltd Autologous Matrix-induced Chondrogenesis Revenue in Global Market (2017-2022)
  7.1.5 JRI Orthopaedics Ltd Key News
7.2 BioTissue
  7.2.1 BioTissue Corporate Summary
  7.2.2 BioTissue Business Overview
  7.2.3 BioTissue Autologous Matrix-induced Chondrogenesis Major Product Offerings
  7.2.4 BioTissue Autologous Matrix-induced Chondrogenesis Revenue in Global Market (2017-2022)
  7.2.5 BioTissue Key News
7.3 Anika Therapeutics
  7.3.1 Anika Therapeutics Corporate Summary
  7.3.2 Anika Therapeutics Business Overview
  7.3.3 Anika Therapeutics Autologous Matrix-induced Chondrogenesis Major Product Offerings
  7.3.4 Anika Therapeutics Autologous Matrix-induced Chondrogenesis Revenue in Global Market (2017-2022)
  7.3.5 Anika Therapeutics Key News
7.4 B. Braun Melsungen
  7.4.1 B. Braun Melsungen Corporate Summary
  7.4.2 B. Braun Melsungen Business Overview
  7.4.3 B. Braun Melsungen Autologous Matrix-induced Chondrogenesis Major Product Offerings
  7.4.4 B. Braun Melsungen Autologous Matrix-induced Chondrogenesis Revenue in Global Market (2017-2022)
  7.4.5 B. Braun Melsungen Key News
7.5 Arthro-Kinetics
  7.5.1 Arthro-Kinetics Corporate Summary
  7.5.2 Arthro-Kinetics Business Overview
  7.5.3 Arthro-Kinetics Autologous Matrix-induced Chondrogenesis Major Product Offerings
  7.5.4 Arthro-Kinetics Autologous Matrix-induced Chondrogenesis Revenue in Global Market (2017-2022)
  7.5.5 Arthro-Kinetics Key News
7.6 Geistlich Pharma
  7.6.1 Geistlich Pharma Corporate Summary
  7.6.2 Geistlich Pharma Business Overview
  7.6.3 Geistlich Pharma Autologous Matrix-induced Chondrogenesis Major Product Offerings
  7.6.4 Geistlich Pharma Autologous Matrix-induced Chondrogenesis Revenue in Global Market (2017-2022)
  7.6.5 Geistlich Pharma Key News
7.7 CartiHeal
  7.7.1 CartiHeal Corporate Summary
  7.7.2 CartiHeal Business Overview
  7.7.3 CartiHeal Autologous Matrix-induced Chondrogenesis Major Product Offerings
  7.7.4 CartiHeal Autologous Matrix-induced Chondrogenesis Revenue in Global Market (2017-2022)
  7.7.5 CartiHeal Key News
7.8 Matricel
  7.8.1 Matricel Corporate Summary
  7.8.2 Matricel Business Overview
  7.8.3 Matricel Autologous Matrix-induced Chondrogenesis Major Product Offerings
  7.8.4 Matricel Autologous Matrix-induced Chondrogenesis Revenue in Global Market (2017-2022)
  7.8.5 Matricel Key News
7.9 Smith & Nephew
  7.9.1 Smith & Nephew Corporate Summary
  7.9.2 Smith & Nephew Business Overview
  7.9.3 Smith & Nephew Autologous Matrix-induced Chondrogenesis Major Product Offerings
  7.9.4 Smith & Nephew Autologous Matrix-induced Chondrogenesis Revenue in Global Market (2017-2022)
  7.9.5 Smith & Nephew Key News
7.10 Zimmer Biomet Holdings
  7.10.1 Zimmer Biomet Holdings Corporate Summary
  7.10.2 Zimmer Biomet Holdings Business Overview
  7.10.3 Zimmer Biomet Holdings Autologous Matrix-induced Chondrogenesis Major Product Offerings
  7.10.4 Zimmer Biomet Holdings Autologous Matrix-induced Chondrogenesis Revenue in Global Market (2017-2022)
  7.10.5 Zimmer Biomet Holdings Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Autologous Matrix-induced Chondrogenesis Market Opportunities & Trends in Global Market
Table 2. Autologous Matrix-induced Chondrogenesis Market Drivers in Global Market
Table 3. Autologous Matrix-induced Chondrogenesis Market Restraints in Global Market
Table 4. Key Players of Autologous Matrix-induced Chondrogenesis in Global Market
Table 5. Top Autologous Matrix-induced Chondrogenesis Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Autologous Matrix-induced Chondrogenesis Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Autologous Matrix-induced Chondrogenesis Revenue Share by Companies, 2017-2022
Table 8. Global Companies Autologous Matrix-induced Chondrogenesis Product Type
Table 9. List of Global Tier 1 Autologous Matrix-induced Chondrogenesis Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Autologous Matrix-induced Chondrogenesis Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Autologous Matrix-induced Chondrogenesis Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Autologous Matrix-induced Chondrogenesis Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Autologous Matrix-induced Chondrogenesis Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Autologous Matrix-induced Chondrogenesis Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Autologous Matrix-induced Chondrogenesis Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Autologous Matrix-induced Chondrogenesis Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2023-2028
Table 30. JRI Orthopaedics Ltd Corporate Summary
Table 31. JRI Orthopaedics Ltd Autologous Matrix-induced Chondrogenesis Product Offerings
Table 32. JRI Orthopaedics Ltd Autologous Matrix-induced Chondrogenesis Revenue (US$, Mn), (2017-2022)
Table 33. BioTissue Corporate Summary
Table 34. BioTissue Autologous Matrix-induced Chondrogenesis Product Offerings
Table 35. BioTissue Autologous Matrix-induced Chondrogenesis Revenue (US$, Mn), (2017-2022)
Table 36. Anika Therapeutics Corporate Summary
Table 37. Anika Therapeutics Autologous Matrix-induced Chondrogenesis Product Offerings
Table 38. Anika Therapeutics Autologous Matrix-induced Chondrogenesis Revenue (US$, Mn), (2017-2022)
Table 39. B. Braun Melsungen Corporate Summary
Table 40. B. Braun Melsungen Autologous Matrix-induced Chondrogenesis Product Offerings
Table 41. B. Braun Melsungen Autologous Matrix-induced Chondrogenesis Revenue (US$, Mn), (2017-2022)
Table 42. Arthro-Kinetics Corporate Summary
Table 43. Arthro-Kinetics Autologous Matrix-induced Chondrogenesis Product Offerings
Table 44. Arthro-Kinetics Autologous Matrix-induced Chondrogenesis Revenue (US$, Mn), (2017-2022)
Table 45. Geistlich Pharma Corporate Summary
Table 46. Geistlich Pharma Autologous Matrix-induced Chondrogenesis Product Offerings
Table 47. Geistlich Pharma Autologous Matrix-induced Chondrogenesis Revenue (US$, Mn), (2017-2022)
Table 48. CartiHeal Corporate Summary
Table 49. CartiHeal Autologous Matrix-induced Chondrogenesis Product Offerings
Table 50. CartiHeal Autologous Matrix-induced Chondrogenesis Revenue (US$, Mn), (2017-2022)
Table 51. Matricel Corporate Summary
Table 52. Matricel Autologous Matrix-induced Chondrogenesis Product Offerings
Table 53. Matricel Autologous Matrix-induced Chondrogenesis Revenue (US$, Mn), (2017-2022)
Table 54. Smith & Nephew Corporate Summary
Table 55. Smith & Nephew Autologous Matrix-induced Chondrogenesis Product Offerings
Table 56. Smith & Nephew Autologous Matrix-induced Chondrogenesis Revenue (US$, Mn), (2017-2022)
Table 57. Zimmer Biomet Holdings Corporate Summary
Table 58. Zimmer Biomet Holdings Autologous Matrix-induced Chondrogenesis Product Offerings
Table 59. Zimmer Biomet Holdings Autologous Matrix-induced Chondrogenesis Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Autologous Matrix-induced Chondrogenesis Segment by Type in 2021
Figure 2. Autologous Matrix-induced Chondrogenesis Segment by Application in 2021
Figure 3. Global Autologous Matrix-induced Chondrogenesis Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Autologous Matrix-induced Chondrogenesis Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Autologous Matrix-induced Chondrogenesis Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Autologous Matrix-induced Chondrogenesis Revenue in 2021
Figure 8. By Type - Global Autologous Matrix-induced Chondrogenesis Revenue Market Share, 2017-2028
Figure 9. By Application - Global Autologous Matrix-induced Chondrogenesis Revenue Market Share, 2017-2028
Figure 10. By Region - Global Autologous Matrix-induced Chondrogenesis Revenue Market Share, 2017-2028
Figure 11. By Country - North America Autologous Matrix-induced Chondrogenesis Revenue Market Share, 2017-2028
Figure 12. US Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Autologous Matrix-induced Chondrogenesis Revenue Market Share, 2017-2028
Figure 16. Germany Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2017-2028
Figure 17. France Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Autologous Matrix-induced Chondrogenesis Revenue Market Share, 2017-2028
Figure 24. China Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2017-2028
Figure 28. India Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Autologous Matrix-induced Chondrogenesis Revenue Market Share, 2017-2028
Figure 30. Brazil Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Autologous Matrix-induced Chondrogenesis Revenue Market Share, 2017-2028
Figure 33. Turkey Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2017-2028
Figure 37. JRI Orthopaedics Ltd Autologous Matrix-induced Chondrogenesis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. BioTissue Autologous Matrix-induced Chondrogenesis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Anika Therapeutics Autologous Matrix-induced Chondrogenesis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. B. Braun Melsungen Autologous Matrix-induced Chondrogenesis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Arthro-Kinetics Autologous Matrix-induced Chondrogenesis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Geistlich Pharma Autologous Matrix-induced Chondrogenesis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. CartiHeal Autologous Matrix-induced Chondrogenesis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Matricel Autologous Matrix-induced Chondrogenesis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Smith & Nephew Autologous Matrix-induced Chondrogenesis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Zimmer Biomet Holdings Autologous Matrix-induced Chondrogenesis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)